Welcome To Parkwalk
Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun-out of UK universities. Our funds seek to generate capital gains for our investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.
Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow.
He has analysed and advised both private and public companies on strategy, development, fund-raising and exits. He was on the advisory team that listed Genentech and Biogen in London, two of the first ‘pure’ University spinouts in the 1980’s and sits on various portfolio company Boards.
Alistair is the Chief Investment Officer at Parkwalk.
Moray headed up the trading activities at Lazard Capital Markets and has a wealth of experience with corporate and institutional clients.
Moray sits on various portfolio company Boards, and is responsible for raising Parkwalk funds.
Enrico sits on the Parkwalk Investment Committee and various Parkwalk portfolio company boards.
Before joining Parkwalk in 2016, Kathy held COO, CFO and Compliance roles at a large event-driven hedge fund.
Kathy previously worked at Schroder Salomon Smith Barney / Citigroup and Merrill Lynch.
Alun sits on the Parkwalk Investment Committee and various Parkwalk portfolio company boards.
Martin sits on the Parkwalk Investment Committee.
Since leaving Andersens, Neil has established and advised a number of companies including Fuel 3D, and he specialises in strategic advisory work.
Ian sits on the Boards of various Parkwalk portfolio companies.
Before Parkwalk, Chloe worked for a technology company after graduating from the University of Southampton.
Prior to joining Parkwalk, Catherine worked at Santander Asset Management after graduating from Oxford Brookes University.
He has 30 years City experience, latterly as head of equity proprietary trading and EMEA equity, derivatives and convertible bond risk at Salomon/Citigroup and then as the founder of Pendragon Capital, a large event-driven hedge fund.
Gordon is an adviser to several hedge funds and sits on the Advisory Boards of several companies and funds, including Bridges Ventures, a highly successful sustainable impact investment fund.
Bill was CEO at Xeros Technology Group plc for the last seven years, taking the company from a standing start in a University of Leeds laboratory through to global sales, IPO and a market cap of c. £200m.
Previously David has worked at Pace Resourcing and Norman Broadbent.
He manages a portfolio of companies and advises the world-leading Royal College of Art on the RCA Angel Club.